Regulation of skeletal muscle protein synthetic and degradative signaling by alanyl-glutamine in piglets challenged with Escherichia coli lipopolysaccharide

Nutrition

Volumn 31, Issue 5, 2015, Pages 749-756

  Zhang, Bolin ^a,c   Yu, Changning ^a,c   Lin, Meng ^a,c   Fu, Ya'nan ^a,c   Zhang, Lin ^a,c   Meng, Meijuan ^a,c   Xing, Shen ^a,c   Li, Jiaolong ^a,c   Sun, Hui ^b   Gao, Feng ^a,c   Zhou, Guanghong ^a,c  

^a Chongqing Metropolitan College of Science and Technology   (China)

^b JILIN AGRICULTURAL UNIVERSITY   (China)

^c NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

Alanyl glutamine; LPS; Piglet; Signaling pathway; Skeletal muscle

Indexed keywords

ALANINE; CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; F BOX PROTEIN; GLUTAMINE; HYDROCORTISONE; INITIATION FACTOR 4A; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MAMMALIAN TARGET OF RAPAMYCIN; MUSCLE RING FINGER 1 PROTEIN; PROTEIN KINASE B; S6 KINASE; SOMATOMEDIN C; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR FOXO; TUMOR NECROSIS FACTOR ALPHA; ALANYLGLUTAMINE; DIPEPTIDE; EIF-4; INITIATION FACTOR; LIPOPOLYSACCHARIDE; MUSCLE PROTEIN; PROTEIN SERINE THREONINE KINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOWN REGULATION; GROWTH RATE; INSULIN BLOOD LEVEL; MOLECULAR MECHANICS; NONHUMAN; PIGLET; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS REGULATION; SIGNAL TRANSDUCTION; WEIGHT GAIN; ANIMAL; CHEMISTRY; DRUG EFFECTS; EATING; ESCHERICHIA COLI; MALE; METABOLISM; PHOSPHORYLATION; PIG; PROTEIN SYNTHESIS; SKELETAL MUSCLE; TREATMENT OUTCOME;

ESCHERICHIA COLI; MAMMALIA;

ANIMALS; DIETARY SUPPLEMENTS; DIPEPTIDES; EATING; ESCHERICHIA COLI; INSULIN-LIKE GROWTH FACTOR I; LIPOPOLYSACCHARIDES; MALE; MUSCLE PROTEINS; MUSCLE, SKELETAL; PEPTIDE INITIATION FACTORS; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; PROTEIN-SERINE-THREONINE KINASES; PROTEOLYSIS; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SIGNAL TRANSDUCTION; SWINE; TOLL-LIKE RECEPTOR 4; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 84933531942     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2014.11.010     Document Type: Article

References (47)

1. Fanzani A., Conraads V.M., Penna F., Martinet W. Molecular and cellular mechanisms of skeletal muscle atrophy: an update. J Cachexia Sarcopenia Muscle 2012, 3:163-179.
2. Orellana R.A., Suryawan A., Wilson F.A., Gazzaneo M.C., Fiorotto M.L., Nguyen H.V., et al. Development aggravates the severity of skeletal muscle catabolism induced by endotoxemia in neonatal pigs. Am J Physiol Regul Integr Comp Physiol 2012, 302:R682-R690.
3. Orellana R.A., O'Connor P.M., Bush J.A., Suryawan A., Thivierge M.C., Nguyen H.V., et al. Modulation of muscle protein synthesis by insulin is maintained during neonatal endotoxemia. Am J Physiol Endocrinol Metab 2006, 291:E159-E166.
4. Liu Y., Chen F., Odle J., Lin X., Zhu H., Shi H., et al. Fish oil increases muscle protein mass and modulates Akt/FOXO, TLR4, and NOD signaling in weanling piglets after lipopolysaccharide challenge. J Nutr 2013, 143:1331-1339.
5. Lambertucci A.C., Lambertucci R.H., Hirabara S.M., Curi R., Moriscot A.S., Alba-Loureiro T.C., et al. Glutamine supplementation stimulates protein-synthetic and inhibits protein-degradative signaling pathways in skeletal muscle of diabetic rats. PLoS One 2012, 7:e50390.
6. Bodine S.C., Stitt T.N., Gonzalez M., Kline W.O., Stover G.L., Bauerlein R., et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy invivo. Nat Cell Biol 2001, 3:1014-1019.
7. Jagoe R.T., Goldberg A.L. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?. Curr Opin Clin Nutr 2001, 4:183-190.
8. Bodine S.C., Latres E., Baumhueter S., Lai V.K., Nunez L., Clarke B.A., et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001, 294:1704-1708.
9. Stitt T.N., Drujan D., Clarke B.A., Panaro F., Timofeyva Y., Kline W.O., et al. The IGF-1/PI3 K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 2004, 14:395-403.
10. Sandri M., Sandri C., Gilbert A., Skurk C., Calabria E., Picard A., et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004, 117:399-412.
11. Zoico E., Roubenoff R. The role of cytokines in regulating protein metabolism and muscle function. Nutr Rev 2002, 60:39-51.
12. Doyle A., Zhang G., Abdel Fattah E.A., Eissa N.T., Li Y.P. Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways. FASEB J 2011, 25:99-110.
13. Lacey J.M., Wilmore D.W. Is glutamine a conditionally essential amino acid?. Nutr Rev 1990, 48:297-309.
14. Rogero M.M., Tirapegui J., Pedrosa R.G., de Castro I.A., de Oliveira Pires I.S. Effect of alanyl-glutamine supplementation on plasma and tissue glutamine concentrations in rats submitted to exhaustive exercise. Nutrition 2006, 22:564-571.
15. Wang H., Jia G., Huang L., Wu C., Wang K. Study on the absorption and transport of different glutamine dipeptides in small intestine of weaned piglets. J Anim Plant Sci 2010, 7:751-759.
16. Cruzat V.F., Bittencourt A., Scomazzon S.P., Leite J.S., de Bittencourt P.I., Tirapegui J. Oral free and dipeptide forms of glutamine supplementation attenuate oxidative stress and inflammation induced by endotoxemia. Nutrition 2014, 30:602-611.
17. Feng Z., Zhou X., Wu F., Yao K., Kong X., Li T., et al. Both dietary supplementation with monosodium l-glutamate and fat modify circulating and tissue amino acid pools in growing pigs, but with little interactive effect. PloS One 2014, 9:e84533.
18. Nicklin P., Bergman P., Zhang B., Triantafellow E., Wang H., Nyfeler B., et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 2009, 136:521-534.
19. Yi D., Hou Y., Wang L., Ding B., Yang Z., Li J., et al. Dietary N-acetylcysteine supplementation alleviates liver injury in lipopolysaccharide-challenged piglets. Br J Nutr 2014, 111:46-54.
20. Liu Y., Huang J., Hou Y., Zhu H., Zhao S., Ding B., et al. Dietary arginine supplementation alleviates intestinal mucosal disruption induced by Escherichia coli lipopolysaccharide in weaned pigs. Br J Nutr 2008, 100:552-560.
21. Council (NRC) NR Nutrient requirements of swine 2012, National Acasdemies Press, Washington, DC.
22. Haynes T.E., Li P., Li X., Shimotori K., Sato H., Flynn N.E., et al. l-Glutamine or l-alanyl-l-glutamine prevents oxidant-or endotoxin-induced death of neonatal enterocytes. Amino Acids 2009, 37:131-142.
23. Wu G., Meier S.A., Knabe D.A. Dietary glutamine supplementation prevents jejunal atrophy in weaned pigs. J Nutr 1996, 126:2578-2584.
24. δδCT method. Methods 2001, 25:402-408.
25. Jiang Z.Y., Sun L.H., Lin Y.C., Ma X.Y., Zheng C.T., Zhou G.L., et al. Effects of dietary glycyl-glutamine on growth performance, small intestinal integrity, and immune responses of weaning piglets challenged with lipopolysaccharide. J Anim Sci 2009, 87:4050-4056.
26. Soto L., Martin A., Millan S., Vara E., López-Calderón A. Effects of endotoxin lipopolysaccharide administration on the somatotropic axis. J Endocrinol 1998, 159:239-246.
27. Leininger M.T., Portocarrero C.P., Houseknecht K.L. Peroxisome proliferator-activated receptor γ1 expression in porcine white blood cells: dynamic regulation with acute endotoxemia. Biochem Biophys Res Commun 1999, 263:749-753.
28. Hsu C., Lee J., Huang H., Wang C., Lee T., Yen H., et al. Effects of supplemental glutamine on growth performance, plasma parameters and LPS-induced immune response of weaned barrows after Ccastration. Asian-Aust J Anim Sci 2012, 25:674-681.
29. Hickson R., Wegrzyn L., Osborne D., Karl I. Alanyl-glutamine prevents muscle atrophy and glutamine synthetase induction by glucocorticoids. Am J Physiol-Reg I 1996, 40:R1165.
30. Newsholme P. Why is l-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection?. J Nutr 2001, 131:2515S-2522S.
31. Johnson R.W. Inhibition of growth by pro-inflammatory cytokines: an integrated view. J Anim Sci 1997, 75:1244-1255.
32. Cruzat V.F., Rogero M.M., Tirapegui J. Effects of supplementation with free glutamine and the dipeptide alanyl-glutamine on parameters of muscle damage and inflammation in rats submitted to prolonged exercise. Cell Biochem Funct 2010, 28:24-30.
33. Cruzat V.F., Pantaleão L.C., Donato J. Oral supplementations with free and dipeptide forms of l-glutamine in endotoxemic mice: effects on muscle glutamine-glutathione axis and heat shock proteins. J Nutr Biochem 2014, 25:345-352.
34. Fan J., Li Y.H., Wojnar M.M., Lang C.H. Endotoxin-induced alterations in insulin-stimulated phosphorylation of insulin receptor, IRS-1, and MAP kinase in skeletal muscle. Shock 1996, 6:164-170.
35. Orellana R.A., Suryawan A., Kimball S.R., Wu G., Nguyen H.V., Jefferson L.S., et al. Insulin signaling in skeletal muscle and liver of neonatal pigs during endotoxemia. Pediatr Res 2008, 64:505-510.
36. Molfino A., Logorelli F., Muscaritoli M., Cascino A., Preziosa I., Fanelli F.R., et al. Metabolic effects of glutamine on insulin sensitivity. Nutr Ther Metab 2010, 28:7-11.
37. Lang C.H., Frost R.A., Vary T.C. Regulation of muscle protein synthesis during sepsis and inflammation. Am J Physiol Endocrinol Metab 2007, 293:E453-E459.
38. Lang C.H., Frost R.A., Jefferson L.S., Kimball S.R., Vary T.C. Endotoxin-induced decrease in muscle protein synthesis is associated with changes in eIF2B, eIF4 E, and IGF-I. Am J Physiol Endocrinol Metab 2000, 278:E1133-E1143.
39. Frost R.A., Nystrom G.J., Lang C.H. Tumor necrosis factor-α decreases insulin-like growth factor-I messenger ribonucleic acid expression in C2 C12 myoblasts via a Jun N-terminal kinase pathway. Endocrinology 2003, 144:1770-1779.
40. Orellana R.A., O'Connor P.M., Nguyen H.V., Bush J.A., Suryawan A., Thivierge M.C., et al. Endotoxemia reduces skeletal muscle protein synthesis in neonates. Am J Physiol Endocrinol Metab 2002, 283:E909-E916.
41. Frost R.A., Lang C.H. MTOR signaling in skeletal muscle during sepsis and inflammation: Where does it all go wrong?. Physiology (Bethesda) 2011, 26:83-96.
42. Orellana R.A., Kimball S.R., Nguyen H.V., Bush J.A., Suryawan A., Thivierge M.C., et al. Regulation of muscle protein synthesis in neonatal pigs during prolonged endotoxemia. Pediatr Res 2004, 55:442-449.
43. Xi P., Jiang Z., Dai Z., Li X., Yao K., Zheng C., et al. Regulation of protein turnover by L-glutamine in porcine intestinal epithelial cells. J Nutr Biochem 2012, 23:1012-1017.
44. Wang X., Hu Z., Hu J., Du J., Mitch W.E. Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 2006, 147:4160-4168.
45. Crossland H., Constantin-Teodosiu D., Gardiner S.M., Constantin D., Greenhaff P.L. A potential role for Akt/FOXO signaling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletal muscle. J Physiol 2008, 586:5589-5600.
46. Macedo Rogero M., Tirapegui J., Pedrosa R.G., Santana de Oliveira Pires I., Alves de Castro I. Plasma and tissue glutamine response to acute and chronic supplementation with l-glutamine and l-alanyl-l-glutamine in rats. Nutr Res 2004, 24:261-270.
47. Zhou W., Li W., Zheng X.-H., Rong X., Huang L.-G. Glutamine downregulates TLR2 and TLR4 expression and protects intestinal tract in preterm neonatal rats with necrotizing enterocolitis. J Pediatr Surg 2014, 49:1057-1063.